GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human tr alpha bound T3 in monoclinic space group

Analyse Crystal structure of human tr alpha bound T3 in monoclinic space group in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2H77
Type
protein
Length
255 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Thra protein
UniProt
Q6FH41
Ligands
T3
Pockets
4 · best druggability 0.83

Structure

x-ray diffraction · 1 distinct chain · 63% helix, 5% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AThra proteinprotein25563% helix, 5% strandQ6FH41

Ligands and binding sites

  • T3 · 3,5,3'triiodothyronine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11860.830.9731T3
21240.420.7619empty
3690.320.7518empty
4560.310.7616empty

Modifications

Observed in the structure: 4 modified (artifact).

Compared structures

  • 2H77 · Crystal structure of human TR alpha bound T3 in monoclinic space group · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.